Trademark: EXONDYS 51 ETEPLIRSEN INJECTION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
EXONDYS 51 ETEPLIRSEN INJECTION
Click here to search for trademarks similar to EXONDYS 51 ETEPLIRSEN INJECTION
Proof of use for EXONDYS 51 ETEPLIRSEN INJECTION
We do not have any records of a proof of use for EXONDYS 51 ETEPLIRSEN INJECTION at this moment.
Click here to add a proof of use for EXONDYS 51 ETEPLIRSEN INJECTION
Possible trademark infringements of EXONDYS 51 ETEPLIRSEN INJECTION
Basic Information about EXONDYS 51 ETEPLIRSEN INJECTION
- Serial Number
- 87656211
- Filing Date
- 23 Oct 2017
- Registration Number
- 5490967
- Registration Date
- 12 Jun 2018
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of EXONDYS 51 ETEPLIRSEN INJECTION on the blockchain with WikiTrademarks.io.
- First use of EXONDYS 51 ETEPLIRSEN INJECTION anywhere
- EXONDYS 51 ETEPLIRSEN INJECTION was first used on 09 Dec 2016 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns EXONDYS 51 ETEPLIRSEN INJECTION?
1. Sarepta Therapeutics, Inc. Cambridge MA
2. Sarepta Therapeutics, Inc. Cambridge MA
3. Sarepta Therapeutics, Inc. Cambridge MA
Correspondent
- Maury M. Tepper, III TEPPER & EYSTER, PLLC
- 3724 BENSON DRIVE
- RALEIGH, NC 27609
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io